CRON

Cronos Group Inc

Stocks

These Are the 3 Best CBD Stocks to Buy Now

by

One of our best CBD stocks to buy now is poised to gain 172% over the next year.

And that’s because the CBD industry is about to explode.

In fact, it’s expecting 3,623% growth in just under three years.

The CBD market is already valued at $591 million since being legalized in the United States in December 2018.

But the Brightfield Group says this figure will soar to $22 billion by 2022.

This type of explosive growth is precisely why we’re so bullish on CBD stocks and the cannabis sector as a whole.

Read more here...

Stocks

These Charts Reveal the "Perfect Price" for These Big Pot Stocks

by

Technical analysis is the study of human psychology, which is represented in the form of price action on a chart. You analyze the stock itself.

Technical analysts look for repeatable patterns and indications that can predict future price movements. Since human psychology and emotions will always be a factor in stock markets, the study of historical price movements of a stock relays the fear and greed associated with that stock.

Let's look at two technical tools that I use often – which is to say, every day the markets are open.

The first shows the movement of price in a group of stocks relative to each other. The second is a broadly watched tool that shows us both the long-term trend of a stock and important areas of support and resistance.

These two tools working together are going to reveal exactly when we should be moving on these stars of the $20 billion North American cannabis sector...

dow jones

Dow Jones Industrial Average Up Early Today After State of the Union Address

by

The Dow Jones Industrial Average was up slightly this morning as investors react to President Trump’s State of the Union Address.

Another busy day of earnings reports will see investors pouring through results and conference calls looking for guidance for the market in 2019. In addition, Federal Reserve Chair Jerome Powell will speak in Washington this evening.

Here are the numbers from Tuesday for the Dow, S&P 500, and Nasdaq...

Trading Strategies

Here's What You Need to Know About Marijuana Mergers

by

We've seen time and again how "takeover targets" provide the opportunity for truly explosive gains. The right company finds the right buyer, and investors gleefully strap in for a virtually instantaneous double- or triple-digit ride.

Dealmaking in general has done some "exploding" of its own over the past few years. 2018 broke records, with some $3.3 trillion worth of dried ink in place by September. That figure was bolstered by the advent of so-called "megadeals" worth more than $5 billion.

Companies have finally figured out the mother of all corporate no-brainers: If you can't beat 'em… buy 'em.

They've realized there's no point in throwing millions (or billions) of your – scratch that, your shareholders' – dollars at a thorny R&D, tech, or PR problem when you can just ride out, find some smaller company that's already done the work, and… acquire, acquire, acquire.

So, when we come across a frenzy of M&A activity in an already rapidly growing, high-profit sector like legal cannabis, it pays to stop and take a good hard look at what's happening. 

Let's take a look at how powerful a moneymaker marijuana deals could be next year...

Trading Strategies

The Aphria Bear Raid Is a Gift in Disguise for Weed Investors

by

In a blistering month for stocks, Aphria has had a particularly bumpy ride.

The Leamington, Canada-based cannabis company was the target of some explosive (and, as we'll see, spurious) allegations from, as it turns out, a firm with substantial short interest. This is a common enough occurrence in the stock market, as Carl Icahn and Bill Ackman's legendary "long vs. short" battle royale over Herbalife Nutrition illustrates. 

The short-seller's allegations focus only on Aphria and one other, small company: Toronto, Ont.-based SOL Global Investments. They have nothing to do with other cannabis firms we follow at the National Institute for Cannabis Investors

But, since the short attack and furious price action last week, I wanted everyone to know what's really happening with Aphria.

It's the truth you won't hear anywhere else - and, even better, a beautifully wrapped-up December buying opportunity... Full Story